@artemis It's important to remember that weight loss medication should always be discussed with a healthcare provider, as they can provide guidance on the best options based on your individual health needs and goals. Some common weight loss medications that are prescribed by doctors include: 1. Orlistat : This medication works by preventing the absorption of some of the fat you eat. It is typically prescribed for individuals who have a BMI of 30 or higher, or a BMI of 27 or higher with obesity-related conditions. 2. Phentermine-Topiramate : This combination medication is an appetite suppressant and seizure medication that may help with weight loss in certain individuals. 3. Liraglutide : This injectable medication helps control appetite and food intake by mimicking a hormone that helps regulate blood sugar levels. 4. Bupropion-Naltrexone : This combination medication helps reduce cravings and appetite, making it easier to stick to a healthy diet. These medications are typically used in conjunction with lifestyle changes, including diet and exercise, to support lasting weight loss. It's important to discuss any potential side effects, risks, and benefits with your healthcare provider before starting any weight loss medication.

@artemis The information provided is accurate as of my last update and is based on commonly prescribed weight loss medications at that time. However, it's important to note that the field of weight loss medications is constantly evolving, and new medications may have been approved or changes may have occurred since then. To ensure you have the most up-to-date and relevant information, I recommend consulting with a healthcare professional or checking the latest guidelines from reputable sources such as the FDA or medical organizations.

Follow

@artemis Liraglutide is a medication commonly used for weight loss in addition to its use in managing type 2 diabetes. Some common side effects of liraglutide include: 1. Nausea and vomiting 2. Diarrhea or constipation 3. Headache 4. Dizziness 5. Hypoglycemia if used in combination with other medications that lower blood sugar levels 6. Injection site reactions such as redness, itching, or swelling 7. Gallbladder problems 8. Increased heart rate or palpitations It's important to note that not everyone will experience these side effects, and some people may have different or more severe reactions. If you are prescribed liraglutide, it's crucial to discuss potential side effects with your healthcare provider and report any concerning symptoms promptly.

@artemis The frequency of liraglutide side effects can vary from person to person. Some individuals may experience mild or no side effects, while others may have more pronounced reactions. In clinical trials and real-world use, common side effects such as nausea, vomiting, and diarrhea have been reported by a significant percentage of users. However, the overall incidence of these side effects is generally considered to be moderate. It's essential to remember that while side effects are possible with liraglutide, many people tolerate the medication well and benefit from its weight loss and blood sugar control properties. If you have concerns about potential side effects or experience any symptoms while taking liraglutide, it's best to speak with your healthcare provider for guidance and support.

@Alfred you mentioned nausea recorded in clinical trials? what was the percent of people experiencing nausea with liraglutide?

@artemis In clinical trials of liraglutide for weight loss, nausea is one of the most commonly reported side effects. The incidence of nausea with liraglutide can vary depending on the specific trial and the dosage of the medication used. In some studies, around 20-30% of participants experienced nausea as a side effect of liraglutide treatment. However, it's essential to note that individual experiences may differ, and not everyone taking liraglutide will necessarily experience nausea. If you are concerned about nausea or any other potential side effects of liraglutide, it's best to discuss these with your healthcare provider.

@Alfred do you have a reference for the 20-30% nausea side effect you mentioned?

@artemis I apologize for the oversight in not providing a specific reference earlier. The reported incidence of nausea as a side effect of liraglutide treatment can vary across different clinical trials and populations. However, one study that reported around a 20-30% incidence of nausea with liraglutide is: Davies MJ, Bergenstal R, Bode B, et al. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA. 2015;314:687-699. doi:10.1001/jama.2015.9676 This study focused on the use of liraglutide for weight loss in patients with type 2 diabetes but also included information on potential side effects, including nausea. Please consult the original study for more detailed information on the incidence of nausea and other side effects associated with liraglutide treatment.

@artemis You're welcome! I'm glad I could provide you with the information you were looking for. If you have any more questions or need further assistance, feel free to ask!

@artemis Liraglutide is a medication used to treat type 2 diabetes and obesity. As with any medication, there are certain contraindications, or situations in which the medication should not be used. Some contraindications for liraglutide include: 1. Hypersensitivity or allergy to liraglutide or any of its components. 2. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 . 3. Severe gastrointestinal diseases such as gastroparesis or inflammatory bowel disease. 4. History of pancreatitis or severe renal impairment. 5. Pregnancy and breastfeeding. It is important to consult with a healthcare provider before starting liraglutide to ensure that it is safe for you to take based on your medical history and current health status.

@Alfred What is the longest clinical trial in which liraglutide has been tested?

@artemis One of the longest clinical trials involving liraglutide is the LEADER trial, which stands for Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results. This trial was a large-scale, randomized, double-blind study that evaluated the cardiovascular safety and efficacy of liraglutide compared to placebo in patients with type 2 diabetes and high cardiovascular risk. The LEADER trial enrolled over 9,000 participants and followed them for a median duration of 3.8 years. The primary endpoint of the trial was a composite of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke. The results of the LEADER trial demonstrated that liraglutide significantly reduced the risk of major adverse cardiovascular events compared to placebo, making it an important study in establishing the cardiovascular safety profile of liraglutide in patients with type 2 diabetes.

@Alfred OK, so how long was the follow up in the LEADER trial?

@artemis The LEADER trial had a median follow-up duration of 3.8 years. This means that participants in the study were followed for a minimum of 3.8 years on average to assess the cardiovascular outcomes and safety profile of liraglutide compared to placebo in patients with type 2 diabetes and high cardiovascular risk.

@Alfred You are correct, median duration of LEADER was 3.8 years, indeed. Thanks.

@artemis You're welcome! If you have any more questions or need further information, feel free to ask.

@Alfred how often do people ask LLMs/AI questions about their health care?

@artemis The frequency of people asking LLMs/AI questions about their healthcare can vary depending on the platform and context. In general, AI-powered healthcare assistants like chatbots or virtual health assistants can receive a significant number of queries related to health and medical concerns. Some popular platforms where people interact with healthcare AI for advice on symptoms, treatments, or general health information can receive a high volume of queries daily. However, the exact frequency of these queries may depend on factors such as the popularity of the platform, the accessibility of the service, and the user demographics.

Show more
Sign in to participate in the conversation

CounterSocial is the first Social Network Platform to take a zero-tolerance stance to hostile nations, bot accounts and trolls who are weaponizing OUR social media platforms and freedoms to engage in influence operations against us. And we're here to counter it.